Tags

Type your tag names separated by a space and hit enter

Risperidone-Induced Nocturnal Enuresis Successfully Treated With Reboxetine.
Clin Neuropharmacol. 2016 May-Jun; 39(3):152-3.CN

Abstract

There are few reports in the literature and scarce research on the topic and the treatment of antipsychotic medication-induced urinary incontinence or nocturnal enuresis (NE) despite the significant frequency of these adverse effects.Treatment for antipsychotic medication-induced urinary incontinence has been reported in relation to clozapine with response to numerous pharmacological strategies such as ephedrine, oxybutynin, intranasal desmopressin, trihexyphenidyl, and amitriptyline.We report a case of NE induced by risperidone which has been successfully treated with reboxetine.To the best of our knowledge, this article is the first report of an atypical antipsychotic medication-induced NE treated with reboxetine.Reboxetine may be an effective treatment for risperidone-induced NE. Further research is required to confirm our finding and apply this treatment for NE caused by other neuroleptics.

Authors+Show Affiliations

Department of Consultation and Liaison Psychiatry, Shaare Zedek Medical Center, affiliated with the Hebrew University School of Medicine, Jerusalem, Israel.No affiliation info available

Pub Type(s)

Case Reports
Journal Article

Language

eng

PubMed ID

26992158

Citation

Mergui, Joseph, and Sol Jaworowski. "Risperidone-Induced Nocturnal Enuresis Successfully Treated With Reboxetine." Clinical Neuropharmacology, vol. 39, no. 3, 2016, pp. 152-3.
Mergui J, Jaworowski S. Risperidone-Induced Nocturnal Enuresis Successfully Treated With Reboxetine. Clin Neuropharmacol. 2016;39(3):152-3.
Mergui, J., & Jaworowski, S. (2016). Risperidone-Induced Nocturnal Enuresis Successfully Treated With Reboxetine. Clinical Neuropharmacology, 39(3), 152-3. https://doi.org/10.1097/WNF.0000000000000142
Mergui J, Jaworowski S. Risperidone-Induced Nocturnal Enuresis Successfully Treated With Reboxetine. Clin Neuropharmacol. 2016 May-Jun;39(3):152-3. PubMed PMID: 26992158.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Risperidone-Induced Nocturnal Enuresis Successfully Treated With Reboxetine. AU - Mergui,Joseph, AU - Jaworowski,Sol, PY - 2016/3/19/entrez PY - 2016/3/19/pubmed PY - 2017/1/20/medline SP - 152 EP - 3 JF - Clinical neuropharmacology JO - Clin Neuropharmacol VL - 39 IS - 3 N2 - There are few reports in the literature and scarce research on the topic and the treatment of antipsychotic medication-induced urinary incontinence or nocturnal enuresis (NE) despite the significant frequency of these adverse effects.Treatment for antipsychotic medication-induced urinary incontinence has been reported in relation to clozapine with response to numerous pharmacological strategies such as ephedrine, oxybutynin, intranasal desmopressin, trihexyphenidyl, and amitriptyline.We report a case of NE induced by risperidone which has been successfully treated with reboxetine.To the best of our knowledge, this article is the first report of an atypical antipsychotic medication-induced NE treated with reboxetine.Reboxetine may be an effective treatment for risperidone-induced NE. Further research is required to confirm our finding and apply this treatment for NE caused by other neuroleptics. SN - 1537-162X UR - https://www.unboundmedicine.com/medline/citation/26992158/Risperidone_Induced_Nocturnal_Enuresis_Successfully_Treated_With_Reboxetine_ L2 - https://doi.org/10.1097/WNF.0000000000000142 DB - PRIME DP - Unbound Medicine ER -